中國同輻(01763.HK)曾跌10%創兩年低 京附屬就核酸檢測問題被立案調查
中國同輻(01763.HK)今日(30日)在官方微信公眾號發表聲明稱,其所屬子公司北京中同藍博醫學檢驗實驗室,正在接受北京警方關於核酸檢測問題的立案調查。此次事件對北京防疫工作造成不利影響,公司對此深表歉意。
此次事件暴露出中國同輻對北京中同藍博的監督管理存在漏洞,公司深感自責,已經第一時間成立工作專班,全力配合有關部門的工作。公司將深刻吸取教訓,立即啟動對北京中同藍博相關責任人從嚴從快嚴肅問責,並接受上級組織對中國同輻相關責任人的問責和處理。
中國同輻(01763.HK)今早曾跌10.2%,低見17.4元創約兩年低,半日跌6.9%,收報18.04元,成交538.1萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.